Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7193 p487-492
13 April 2002


News summary

ABPI opposes number plates for packs The proposed "number plate" system for drug packaging is poorly-thought out and could put patient's lives at risk, Andrew Curl, deputy director general of the Association of British Pharmaceutical Industry, said this week...[more]

No place for pharmacy on PCTs Although community pharmacists, like other health services contractors, are eligible for appointment to the executive committees or boards of primary care trusts in England, the Department of Health says it will not be a requirement for any to be appointed. However, PCT boards will now have to include a director of public health...[more]

EHC ruling imminent The High Court judge hearing the case brought by the Society for the Protection of Unborn Children is expected to give his ruling shortly...[more]

Six generics companies are under investigation for NHS price fraud Six generics companies are under investigation for conspiracy to defraud the National Health Service...[more]

Recruitment squeeze helps employees The impact of the fallow year and continuing demand for pharmacists made last year particularly difficult for recruitment, according to the Institute of Pharmacy Management International's 12th annual survey. However, employee pharmacists have benefited through salary increases and the reappearance of incentive schemes...[more]

Ovarian cancer risk may be limited to specific HRT Hormone replacement therapy (HRT) with sequential rather than continuous progestogen might increase risk of ovarian cancer...[more]

HRT reduces the risk of breast arterial hardening Researchers have confirmed that hormone replacement therapy reduces the risk of developing breast arterial calcification (BAC), a possible marker for vascular disease...[more]

No increase in English oxygen budget The Department of Health has decided not to increase the budget for domiciliary oxygen services in England for 2002–03...[more]

Domestic OTC sales rise by 10 per cent Sales of non-prescription medicines in the United Kingdom grew by 10 per cent at manufacturers' prices in 2001...[more]

Call to reform unfair NHS charges Prescription charges should be significantly reduced, and other National Health Service charges reformed, because they form a confusing mishmash of taxes on illness, says the Association of Community Health Councils for England and Wales...[more]

Dispensing doctors lose VAT case Dispensing doctors have lost a legal challenge to a Customs & Excise ruling that they cannot reclaim VAT on medicines for direct administration to patients...[more]

Hospital recruitment goes online Pharmacy students can now apply for hospital preregistration training places in England and Wales for 2003 online...[more]

Fish oil capsules exceed European dioxin limit to be enacted on 1 July 2002 Out of 15 brands of fish oil capsules analysed by the Food Safety Authority of Ireland, 10 contained levels of dioxins above the maximum limit set out by an EC regulation that comes into force on 1 July...[more]

Antiarrhythmic role for fish oil Daily supplements of n-3 polyunsaturated fatty acids, which are found in fish oil, halve the risk of sudden death in patients who have survived a recent myocardial infarction (MI), say researchers...[more]

Diuretics benefit certain patients Diuretic therapy is more effective in lowering risk of myocardial infarction (MI) or stroke than other antihypertensives in patients with a specific genetic variation, researchers have found...[more]

Genetic variation causes increased warfarin side effects Patients with specific genetic variations are at increased risk of bleeding events and are less stable on maintenance therapy with warfarin, researchers have found...[more]

EMEA caught on the hop by increased number of orphan drug applications Applications for designating medicines as orphan drugs have exceeded the expectations of the European Agency for the Evaluation of Medicinal Products (EMEA)...[more]

EMEA seeks more funds for drug safety work and new database The European Agency for the Evaluation of Medicinal Products is seeking a €24m (£15m) increase in its budget to pay for increased pharmacovigilance work, including a new computerised drug safety system...[more]

Intrathecal drug guidance clarified Additional information about guidance on administration of intrathecal chemotherapy has been set out by the Department of Health...[more]

High disability rate in children born to women treated for epilepsy confirmed A new study that assesses the long-term consequences of intrauterine drug exposure for children born to mothers with epilepsy shows that the malformation rate in children exposed to epilepsy treatment is 13.8 per cent, a figure comparable with results of other studies...[more]

St John's wort effect not proven for major depression Hypericum perforatum (St John's wort) should not be used as a substitute for standard clinical care of proven efficacy, including antidepressant medication and specific psychotherapies, say researchers...[more]

NICE endorses smoking cessation therapies for determined quitters Bupropion (Zyban) and nicotine replacement therapy (NRT) should be prescribed for smokers who wish to stop smoking, the National Institute for Clinical Excellence has recommended this week...[more]

MeReC reviews AF therapy The latest issue of the MeReC Bulletin reviews the drug treatment of atrial fibrillation...[more]


  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal